These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 11790713)

  • 1. Effect of ramipril and vitamin E on atherosclerosis.
    Iuliano L; Micheletta F; Violi F; Spagnoli LG
    Circulation; 2002 Jan; 105(2):E5-6. PubMed ID: 11790713
    [No Abstract]   [Full Text] [Related]  

  • 2. ACE inhibitor inhibits atherosclerosis.
    Harv Heart Lett; 2001 May; 11(9):6-7. PubMed ID: 11410954
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE).
    Lonn E; Yusuf S; Dzavik V; Doris C; Yi Q; Smith S; Moore-Cox A; Bosch J; Riley W; Teo K;
    Circulation; 2001 Feb; 103(7):919-25. PubMed ID: 11181464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study design and baseline characteristics of the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E: SECURE.
    Lonn EM; Yusuf S; Doris CI; Sabine MJ; Dzavik V; Hutchison K; Riley WA; Tucker J; Pogue J; Taylor W
    Am J Cardiol; 1996 Oct; 78(8):914-9. PubMed ID: 8888665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modifying the natural history of atherosclerosis: the SECURE trial.
    Lonn E
    Int J Clin Pract Suppl; 2001 Jan; (117):13-8. PubMed ID: 11715353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ramipril can do more. Halting progression of atherosclerosis].
    MMW Fortschr Med; 2001 Sep; 143(35-36):45. PubMed ID: 11584530
    [No Abstract]   [Full Text] [Related]  

  • 7. Randomized, placebo-controlled trial of the angiotensin-converting enzyme inhibitor, ramipril, in patients with coronary or other occlusive arterial disease. PART-2 Collaborative Research Group. Prevention of Atherosclerosis with Ramipril.
    MacMahon S; Sharpe N; Gamble G; Clague A; Mhurchu CN; Clark T; Hart H; Scott J; White H
    J Am Coll Cardiol; 2000 Aug; 36(2):438-43. PubMed ID: 10933355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An ACE inhibitor to coronary patients: ramipril reduces mortality according to HOPE trial.
    Prescrire Int; 2001 Apr; 10(52):62-3. PubMed ID: 11718163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The HOPE (Heart Outcomes Prevention Evaluation) Study: the design of a large, simple randomized trial of an angiotensin-converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events. The HOPE study investigators.
    Can J Cardiol; 1996 Feb; 12(2):127-37. PubMed ID: 8605634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin E does not prevent cardiovascular events in high-risk patients.
    Flynn T; Stevermer JJ
    J Fam Pract; 2000 Apr; 49(4):372-3. PubMed ID: 10778845
    [No Abstract]   [Full Text] [Related]  

  • 11. Why were the results of the Heart Outcomes Prevention Evaluation (HOPE) trial so astounding?
    Mancini GB; Stewart DJ
    Can J Cardiol; 2001 May; 17 Suppl A():15A-7A. PubMed ID: 11381289
    [TBL] [